Liquid embolic agents for renal angiomyolipoma embolisation achieved the greatest tumour reduction with low re-intervention rates, while coil-only embolisation showed inferior outcomes.
Do liquid embolic agents improve tumour reduction and reduce re-intervention rates compared to coil-only embolisation in patients with renal angiomyolipoma?
Liquid embolic agents are superior to coil-only embolisation for achieving tumour reduction and minimizing re-intervention in the treatment of renal angiomyolipoma.
SAE is a safe and effective treatment for r-AML in both elective and emergency settings. Liquid embolic agents achieved the greatest tumour reduction with low re-intervention rates, while coil-only embolisation showed inferior outcomes and should be avoided where possible.
O'Shea et al. (2026) studied this question. Liquid embolic agents for renal angiomyolipoma embolisation achieved the greatest tumour reduction with low re-intervention rates, while coil-only embolisation showed inferior outcomes.